|
⚲
|
| Keyboard |
| Tadd Wessel | |
|---|---|
| Firm | |
| Address | 220 East 42nd Street 37th Floor New York, NY 10017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Petrichor Capital Partners Fund II LP | 021-543972 | Executive Officer | |||
| Health Outlook Corp | 021-521985 | Director | 1.4 M of 5.0 M |
||
| Health Outlook Corp | 021-502446 | Director | 2.9 M of 3.5 M |
||
| Health Outlook Corp | 021-488233 | Director | 4.0 M of 4.0 M |
||
| Palvella Therapeutics Inc | 021-469329 | Director | 9.7 M of 37.7 M |
||
| Health Outlook Corp | 021-448784 | Director | 5.6 M of 8.2 M |
||
| Persivia Inc | 021-345756 | Director | 3.1 M of 6.2 M |
||
| Persivia Inc | 021-345760 | Director | 1.9 M of 3.7 M |
||
| Petrichor Healthcare Capital Management LP | |||||
| POF I Co-Invest LP | 021-396924 | Executive Officer | 37.0 M | 98.4 M | |
| Scion Life Sciences I LLC | 021-430236 | Executive Officer | 172.2 M | 296.2 M | |
| Petrichor Opportunities Fund I LP | 021-290826 | Executive Officer | 153.3 M | 394.5 M | |